Global Blood Cancer Detection Market Growth 2025-2031

The global Blood Cancer Detection market size is predicted to grow from US$ 2667 million in 2025 to US$ 3831 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

Diagnosis of hematological tumors is the analysis and diagnosis of tumors using blood

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the “Blood Cancer Detection Industry Forecast” looks at past sales and reviews total world Blood Cancer Detection sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Cancer Detection sales for 2025 through 2031. With Blood Cancer Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Cancer Detection industry.

This Insight Report provides a comprehensive analysis of the global Blood Cancer Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Cancer Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Cancer Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Cancer Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Cancer Detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Cancer Detection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Serve

Detection Kit

Segmentation by Application:

Clinical Laboratory

Hospital

Academic Research Institution

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Abbott Laboratories

F.Hoffman-LaRoche

QIAGEN

Thermo Fisher Scientific

lllumina

Bio-Rad Laboratories

MolecularMD

ArcherDX

ARUP Laboratories

Asuragen

Invivoscribe

AdaptiveBiotechnologies

Amoy Diagnostics

ELITechGroup

VelaDiagnostics

Gentronix

BiolVT

SAGA Diagnostics

Olink

Cancer Diagnostics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Cancer Detection market?

What factors are driving Blood Cancer Detection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Cancer Detection market opportunities vary by end market size?

How does Blood Cancer Detection break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.